Showing results (811-820 of 2,915) with videos related to

Sort By:
Pageof 292
Cancer Gene Therapy|October 19, 2002
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsJ Mark Sloan, Michael H Kershaw, Christopher E Touloukian, et al.
Cancer Gene Therapy|December 19, 2002
Prospects for CD40-directed experimental therapy of human cancerAlex W Tong, Marvin J Stone
Cancer Gene Therapy|December 19, 2002
Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylaseWilliam B Parker, Paula W Allan, Abdalla E A Hassan, et al.
Cancer Gene Therapy|December 19, 2002
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4NHelen O McCarthy, Anita Yakkundi, Verna McErlane, et al.
Cancer Gene Therapy|December 19, 2002
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancerChoon-Taek Lee, Kyung-Ho Park, Yasushi Adachi, et al.
Cancer Gene Therapy|December 19, 2002
Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancerHironari Dehari, Yoshinori Ito, Takafumi Nakamura, et al.
Cancer Gene Therapy|July 24, 2002
Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptorTadashi Ogawa, Koichi Takayama, Nobuyuki Takakura, et al.
Cancer Gene Therapy|April 8, 2003
Lipoplexes with alkylphospholipid as new helper lipid for efficient in vitro and in vivo gene transfer in tumor therapyReinhard Zeisig, Angelika Ress, Iduna Fichtner, et al.
Cancer Gene Therapy|January 5, 2002
Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozymeF Bi, D Fan, H Hui, et al.
Cancer Gene Therapy|January 5, 2002
Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1beta mediated by a tumor-specific vector, HVJ cationic liposomesT Miyata, S Yamamoto, K Sakamoto, et al.
Pageof 292